EPOPROSTENOL TEVA ® 0.5 MG

Država: Izrael

Jezik: engleski

Izvor: Ministry of Health

Aktivni sastojci:

EPOPROSTENOL AS SODIUM 0.5 MG

Dostupno od:

SALOMON,LEVIN & ELSTEIN LTD

ATC koda:

B01AC09

Farmaceutski oblik:

POWDER AND SOLVENT FOR SOLUTION FOR INFUSION

Administracija rute:

I.V

Proizveden od:

TEVA PARENTERAL MEDICINES INC, USA

Terapijska grupa:

EPOPROSTENOL

Terapijske indikacije:

Epoprostenol Teva is indicated for the long-term intravenous treatment of primary arterial pulmonary hypertension and arterial pulmonary hypertension associated with the scleroderma spectrum of disease in NYHA class III and class IV patients who do not respond to conventional therapy.

Datum autorizacije:

2009-11-01